N
Nutriband Inc (NTRB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$5.81
-0.29 (-4.75%)
Market Cap: $74.15M
Last updated: Nov 17, 2026 at 11:03 AM ET
Nutriband Inc (NTRB) Valuation Multiples
Nutriband (NTRB) trades at 43.7x sales and 13.3x book value. Its P/S of 43.7x is above its 5-year median of 23.5x. Its forward P/E is 370.4x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 370.4x |
| Price to sales | 43.7x |
| Price to book | 13.3x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/B is 64.2% above 8.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 43.7x | 23.5x | N/A |
| P/B | 13.3x | 4.5x | 8.1x |
Valuation History
Over the 6 year ends shown, its P/S ranged from 9.6x in 2023 to 124.0x in 2020.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $4.54 | 22.2x | 7.3x |
| 2024 | $4.71 | 23.3x | 4.7x |
| 2023 | $2.32 | 9.6x | 3.2x |
| 2022 | $3.60 | 16.3x | 2.9x |
| 2021 | $10.08 | 64.0x | 5.3x |
| 2020 | $15.00 | 124.0x | 11.4x |
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NTRB
What is NTRB's forward P/E ratio?
Nutriband has a forward P/E ratio of 370.4x.
Is NTRB stock overvalued?
GNG's valuation label for NTRB is Overvalued.
What is NTRB's price to sales ratio?
Nutriband has a price to sales ratio of 43.7x.
NTRB pages: Overview, Earnings, Financials, Valuation, Competitors